|
Consolidated Statements Of Operations And Comprehensive Loss (USD $)
In Thousands, except Share data, unless otherwise specified
|
12 Months Ended |
|
Dec. 31, 2011
|
Dec. 31, 2010
|
Dec. 31, 2009
|
| Net revenue |
$ 63,656 |
$ 76,459 |
$ 52,114 |
| Cost of revenue |
(42,932) |
(51,117) |
(35,183) |
| Gross profit |
20,724 |
25,342 |
16,931 |
| Operating expenses: |
|
|
|
| Research and development, net |
(21,326) |
(19,641) |
(16,920) |
| Selling and marketing |
(12,836) |
(6,221) |
(3,867) |
| General and administrative |
(12,735) |
(9,491) |
(10,798) |
| Assets impairment |
(6,599) |
|
|
| Total operating expenses |
(53,496) |
(35,353) |
(31,585) |
| Loss from operations |
(32,772) |
(10,011) |
(14,654) |
| Other income/(expense): |
|
|
|
| Interest income |
673 |
1,071 |
1,422 |
| Foreign exchange gain/(loss), net |
1,678 |
634 |
(7) |
| Gain on disposal of marketable equity securities |
1,517 |
367 |
2,461 |
| Others, net |
501 |
466 |
408 |
| Loss before income taxes and share of profit of an unconsolidated affiliate subject to equity accounting |
(28,403) |
(7,473) |
(10,370) |
| Income tax (expense)/benefit |
861 |
(750) |
(532) |
| Net loss before share of profit of an unconsolidated affiliate subject to equity accounting |
(27,542) |
(8,223) |
(10,902) |
| Equity in profit of an unconsolidated affiliate subject to equity accounting, net of tax |
|
|
3 |
| Net loss from continuing operations |
(27,542) |
(8,223) |
(10,899) |
| Loss from discontinued operations, net of tax |
(12,576) |
(16,884) |
(9,782) |
| Net loss |
(40,118) |
(25,107) |
(20,681) |
| Loss attributable to non-controlling interest |
(11,918) |
(6,463) |
(1,914) |
| Loss attributed to Vimicro International Corporation |
(28,200) |
(18,644) |
(18,767) |
| Other comprehensive income |
|
|
|
| Foreign currency translation adjustment |
3,309 |
2,535 |
93 |
| Unrealized gain/(loss) on marketable equity securities |
(1,368) |
913 |
484 |
| Comprehensive loss |
(38,177) |
(21,659) |
(20,104) |
| Comprehensive loss attributable to non-controlling interest |
(10,444) |
(5,431) |
(1,869) |
| Comprehensive loss attributable to Vimicro International Corporation |
(27,733) |
(16,228) |
(18,235) |
| Loss per share - basic and diluted |
|
|
|
| continuing operations |
$ (0.10) |
$ (0.02) |
$ (0.06) |
| discontinued operations |
$ (0.09) |
$ (0.11) |
$ (0.07) |
| Total loss per share - basic and diluted |
$ (0.19) |
$ (0.13) |
$ (0.13) |
| Weighted-average number of ordinary shares outstanding |
|
|
|
| Basic and diluted |
145,123,889 |
147,815,985 |
143,182,200 |
| Components of share-based compensation expenses are included in the following expense captions: |
|
|
|
| Share-based compensation expense |
(2,421) |
(4,063) |
(8,955) |
|
Research And Development, Net [Member]
|
|
|
|
| Components of share-based compensation expenses are included in the following expense captions: |
|
|
|
| Share-based compensation expense |
(782) |
(1,918) |
(3,119) |
|
Selling And Marketing [Member]
|
|
|
|
| Components of share-based compensation expenses are included in the following expense captions: |
|
|
|
| Share-based compensation expense |
(80) |
(190) |
(261) |
|
General and Administrative [Member]
|
|
|
|
| Components of share-based compensation expenses are included in the following expense captions: |
|
|
|
| Share-based compensation expense |
$ (1,559) |
$ (1,955) |
$ (5,575) |